Abuse Deterrent Studies

Abuse Deterrent Studies

Abuse deterrence studies from the experts

Intellipharmaceutics has a long history in developing and working with Abuse Deterrent Formulations (ADFs). We have developed and submitted our own ADFs to the U.S. FDA and as a result have experience solving the unique development, testing and regulatory issues that are associated with opioids in general and Abuse Deterrent Formulations in particular.

We offer the following Category 1 studies capabilities:

  • Design study protocols to evaluate Category 1 abuse deterrent medications
  • Determine whether and to what extent the abuse-deterrent properties of a formulation can be easily defeated or compromised.

Our services team is waiting to hear from you.

Contact Contract Services